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Abstract 
Central neuropeptide Y (NPY) signaling participates in the regulation of cardiac autonomic outflow, 
particularly via activation of NPY-Y1 receptors (Y1Rs). However, the specific brain areas and 
neural pathways involved have not been completely identified yet. Here, we evaluate the role of 
hippocampal Y1Rs in the modulation of the autonomic control of cardiac function using a 
conditional knockout mouse model. Radiotelemetric transmitters were implanted in 4-month-old 
male mice exhibiting reduced forebrain expression (rfb) of the Y1R (Npy1rrfb, n=10) and their 
corresponding controls (Npy1r2lox, n=8). ECG signals were recorded (i) during resting conditions, 
(ii) under selective pharmacological manipulation of cardiac vagal activity, and (iii) during acute and 
chronic psychosocial stress challenges, and analyzed via time- and frequency-domain analysis of 
heart rate variability. Npy1rrfb mice showed a lower Npy1r mRNA density in the dentate gyrus and 
in the CA1 region of the hippocampus. Under resting undisturbed conditions, Npy1rrfb mice 
exhibited (i) a higher heart rate, (ii) a reduced overall heart rate variability, and (iii) lower values of 
the indices of vagal modulation compared to Npy1r2lox counterparts. Following pharmacological 
vagal inhibition, heart rate was higher in control but not in Npy1rrfb mice compared to their 
respective baseline values, suggesting that tonic vagal influences on heart rate were reduced in 
Npy1rrfb mice. The magnitude of the heart rate response to an acute psychosocial stressor was 
smaller in Npy1rrfb mice compared to  Npy1r2lox counterparts (likely due to a concurrent lower vagal 
withdrawal), even though absolute heart rate values did not differ between the two groups. These 
findings suggest that reduced hippocampal Y1R expression leads to a decrease in resting vagal 
modulation and heart rate variability, which, in turn, may determine a reduced cardiac autonomic 
responsiveness to acute stress challenges. 
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1. Introduction 
Neuropeptide Y (NPY) is widely distributed in the central nervous system [1], with particularly high 
concentrations in the hypothalamus [2] and limbic system [3, 4]. NPY is involved in the regulation 
of a variety of complex functions that range from food intake to emotional state [5]. These effects 
are mediated by multiple G-protein coupled receptor subtypes, which are characterized by different 
tissue localization and pharmacological properties [6-8]. In particular, accumulating evidence 
suggests that central Y1 receptors (Y1Rs) play a critical role in the inhibition of the sympathetic 
outflow to peripheral tissues. For example, it has been shown in rats that i.c.v. (lateral ventricle) 
administration of the Y1R agonist [Leu31,Pro34]NPY reduces basal noradrenaline release from the 
paraventricular nucleus of the hypothalamus (PVN) [9], the major site of autonomic regulation via 
projections to the rostral ventro-lateral medulla and the spinal cord. Moreover, NPY, acting on 
Y1Rs, decreases noradrenaline overflow from both the hypothalamus and the medulla in vitro [10]. 
A recent study has elegantly demonstrated that NPY released from the arcuate nucleus (ARC) 
suppresses tyrosine hydroxylase (TH) expression in the PVN via activation of Y1Rs [11]. This 
effect was associated with a reduction in TH expression in the locus coeruleus and other regions 
(such as the A1/C1 cell groups) in the brain stem [11], which would ultimately lead to a reduced 
sympathetic outflow to peripheral tissues [11]. Supporting this view, nanoinjection of NPY into the 
PVN decreases heart rate (HR), sympathetic nerve activity and baroreflex control of HR in 
anesthetized rats via activation of Y1Rs and Y5Rs [12]. In mice, Tovote and colleagues observed 
that bilateral i.c.v. injections of NPY dose-dependently induced bradycardia and also blunted the 
tachycardic response to a fear conditioning challenge [13], the latter via Y1R-mediated inhibition of 
stress-induced sympathetic activation [13]. Similarly, global knockout of the Y1 receptor gene in 
mice led to a larger HR activation during social defeat stress [14]. These findings support the view 
that NPY-Y1R signaling may play an important role also in constraining stress-induced sympathetic 
activation [15, 16]. While the relationship between NPY-Y1R signaling in the ARC/PVN axis and 
sympathetic nervous system has been documented, there is little known about the neural 
pathways and mechanisms that control it. Indeed, in contrast with the above reported observations 
that are suggestive of a central sympathetic inhibitory role of Y1Rs, global knockout of the NPY-
Y1R gene in mice led to resting bradycardia, which was likely due to a reduced basal sympathetic 
tone and increased parasympathetic activity [14]. This apparent contradiction might be ascribed to 
compensatory effects that are due to gene inactivation in early development and/or might underlie 
different roles played by Y1Rs at different levels in the central autonomic network.
Recently, a conditional knockout mouse model in which the inactivation of the Y1 receptor gene is 
restricted to excitatory neurons in the hippocampus, in particular when mice were reared by foster 
mothers exhibiting high levels of maternal care, has been developed [17]. Therefore, this animal 
model may be useful for understanding the contribution of hippocampal Y1Rs for central autonomic 
cardiovascular control. In order to reach this goal, autonomic modulation of cardiac function was 
assessed in the above mentioned conditional knockout mouse model during (i) baseline conditions, 
(ii) selective pharmacological autonomic manipulations, and (iii) acute and chronic psychosocial 
stress challenges, via time- and frequency-domain analysis of HR variability (HRV).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Methods 
2.1. Animals, housing conditions and ethics statements  
Experiments were performed on 4-month-old male conditional knockout mice (Npy1rrfb, n=10) and 
their control littermates (Npy1r2lox, n=8) that were matched for body weight.  Npy1rrfb and Npy1r2lox 
mice (background strain: C57BL/6J) were generated following the breeding scheme described by 
Bertocchi et al. (see [17] for details). Briefly, Npy1r2lox/Tg -tTA/LC1 mice (named herein Npy1rrfb) 
were generated using doxycycline dependent control of the Cre-LoxP system. Using this approach, 
Bertocchi et al. [17] achieved the deletion of Npy1r in the hippocampal CA1 and CA3 pyramidal 
and in the dentate gyrus granule cell layers. Since the phenotype of Npy1rrfb mutants becomes 
evident only in males reared by foster mothers showing high level of maternal cares versus 
adopted pups, immediately after birth the Npy1rrfb male mice used in our study were fostered to 
Dox-naive CD1 dams, which display high levels of maternal cares (unpublished data). Littermates 
comprising Npy1r2lox/Tg -tTA, Npy1r2lox/TgLC1, and Npy1r2lox genotypes were used as controls 
(named herein Npy1r2lox controls), as in Bertocchi et al. [17]. After weaning, mice were kept in same 
sex sibling groups in 40x20x20 cages in rooms with humidity- (50 ± 10%) and temperature- (22 ± 2 
°C) controlled conditions, with food and water available ad libitum. Experiments were performed 
during the light phase of the 12-h light/dark cycle (lights on at 7 a.m.). All experimental procedures 
and protocols were approved by the Veterinarian Animal Care and Use Committee of Parma 
University and conducted in accordance with the European Community Council Directives of 22 
September 2010 (2010/63/UE). 
 
2.2. Transmitter implantation and radiotelemetry system 
ECG (sampling frequency 2 KHz), body temperature (T, °C) and locomotor activity (LOC, counts 
per minute, cpm) signals were recorded by a radiotelemetry system. It consisted of transmitters
TA10ETA-F20, Data Sciences Int., St.Paul, MN, USA) and  platform receivers (RPC-1, Data 
Science Int., St.Paul, MN, USA), which were connected to a computer containing Art-Gold 1.10 
data acquisition system (Data Science Int., St.Paul, MN, USA). Transmitter implantation was 
performed under isoflurane anesthesia (2% in 100% oxygen), as previously described [18]. The 
dorsal surface of the xyphoid process and in the anterior mediastinum close to the right atrium, 
respectively. This surgical procedure guarantees high quality ECG recordings, even during 
sustained physical activity. After surgery, mice were individually housed, injected with Gentamicin 
sulphate (Aagent, Fatro, 1ml/kg, S.C.) and allowed two weeks of recovery before the beginning of 
the experimental recordings. 
 
2.3. General experimental outline 
The timeline of the experimental protocol is depicted in Figure 1. Specific experimental procedures 
and data analysis are described in the following sections. After recovery from surgery, mice were 
weighed and left undisturbed in their home cages for 6 days (days 1-6). On days 7 and 9, they 
underwent pharmacological autonomic challenges. From day 12 to day 25, mice were housed in 
the cage of a dominant mouse in order to mimic a chronic psychosocial stress condition. At the end 
of the experimental protocol, mice were sacrificed by decapitation. Brains were rapidly removed 
and immediately frozen in liquid nitrogen, then stored at -80° C until analysis. 
 
2.4. Daily rhythms of HR, HRV, T and LOC 
ECG, T and LOC signals were sampled around-the-clock for 2 min every 30 min in baseline 
conditions (Basal Rhythms, days 1-6) and during chronic psychosocial stress (Stress Rhythms 1, 
days 16-19; Stress Rhythms 2, days 22-25) (Fig. 1). Heart rate (HR, beats per minute, bpm), HRV 
parameters (see ECG analysis section for details), T and LOC were calculated as mean values of 
the 12-h light and 12-h dark phases of the daily cycle for each recording day. Subsequently, they 
were further averaged as mean values of the light and dark phase for each recording period.  
 
2.5. Pharmacological autonomic challenge 
On day 7 and 9 (Fig. 1), mice were intraperitoneally injected with either i) vehicle (0.9% NaCl, 1 
ml/kg) or ii) methylscopolamine (muscarinic receptor antagonist, 0.1 mg/kg), with a rotational 
design. Continuous ECG recordings were performed prior to (for 30 min, baseline condition) and 
following (for 60 min) each injection, with the mice in their home cages.  
 
2.6. Chronic psychosocial stress 
In the present study we applied a modified version of the standard chronic psychosocial stress 
paradigm [18, 19], which is based on the classical resident-intruder test [20]. Six-month-old CD1 
mice were housed with a female partner for 1 week and then individually housed and trained to 
aggressively defend their territory from same sex mice intruders that were younger and lighter. 
These dominant animals served as residents. Each experimental mouse was introduced as an 
intruder in the home cage of a resident male; once there, it was attacked and subordinated by the 
resident mouse (social defeat). After 10 min, the two animals were separated by a perforated 
polystyrene-metal partition that divided the cage into two equal-area sections. Thus, the intruder 
mouse was protected from direct physical contact but it was in constant olfactory, auditory and 
visual contact with the resident (psychosocial challenge). The partition was removed five times 
during the experimental protocol (Fig. 1) at an unpredictable time between 9:00 and 13:00 h and 
repositioned after 2 min to prevent injuries. After each interaction, the experimental mice were 
closely inspected for any improper injury and were excluded from further procedures in case they 
were wounded. During the first episode of agonistic interaction, continuous ECG recordings were 
performed for 30 min in baseline conditions (with the mice in their home cage), during the 10-min 
agonistic interaction, and for 60 min after the intruders were again separated from the residents by 
the partition.  
 
2.7. Heart rate variability (HRV) analysis 
HRV analysis was carried out on ECG recordings using ChartPro 5.0 software (ADInstrument, 
Sydney, Australia), based on the recommendations for HRV analysis in mice [21].  Initially, each 
ECG recording was split in 2-min temporal segments (0-2 min; 2-4 min; etc.). Ectopic beats and 
recording artifacts were then removed following visual inspection of unprocessed ECG signals. 
Subsequently, HR and time- and frequency-domain parameters of HRV were quantified for each 2-
min time period. In the time domain, the root mean square of successive R-R interval differences 
(RMSSD, ms) was quantified; this index reflects short-term, high-frequency variations of RR 
interval, which are mainly due to cardiac parasympathetic activity [22]. In the frequency-domain, 
the power spectrum was obtained with a fast Fourier transform-
periodogram: 256 points, 50% overlap, and Hamming window). The following parameters were 
evaluated: i) the total power of the spectrum (ms2), which reflects all the cyclic components 
responsible for variability [23], and ii) the power (ms2) of the high frequency band (HF, 1.5-5.0 Hz), 
which reflects the activity of the parasympathetic nervous system and is related to respiratory sinus 
arrhythmia [24].  
 
2.8. In Situ Hybridization for Npy1r mRNA 
In situ hybridization was performed on 14- m-thick coronal brain sections, according to the 
protocol reported by Wisden and Morris [25], in Npy1rrfb (n=4) and Npy1r2lox (n=4) mice. Four 
different 40-/45-mer oligonucleotide S35-labeled probes were simultaneously used to increase the 
signal and the reaction was carried out as previously described [17]. The area of interest of clearly 
distinguishable nuclei was defined following the boundaries of the labeled regions [dentate gyrus 
granule cell layer (DG)], whereas three to four spots were used for each slice in poorly contrasted 
regions [CA1 pyramidal cell layer (CA1) and CA3 pyramidal cell layer (CA3)]. Optical densities (OD 
unit) were measured and averaged after a rodboard calibration. Background was measured by 
averaging three to five spots in the surrounding blank region of the autoradiogram, then subtracted 
from the corresponding nucleus value. 
. 
2.9. Statistical analysis 
All statistical analyses were performed using the software package SPSS (version 22). Two-way 
ANOVA for repeated measures with group  as between-subject factor (2 levels: Npy1rrfb and 
Npy1r2lox) was applied for ECG and telemetric data obtained from: i) baseline around-the-clock 
recordings, with time  as within-subject factor (6 levels: day 1, 2, 3, 4, 5 and 6); ii) pharmacological 
challenges, with time  as within-subject factor (4 levels: baseline; post injection 1, 2, 3); iii) first 
episode of social defeat, with time  as within-subject factor (8 levels: baseline, fight, sensory 
contact 1, 2, 3, 4, 5 and 6); iv) around-the-clock recordings during chronic social stress, with time  
as within-subject factor (3 levels: baseline, stress 1 and stress 2). Follow-up analyses were 
outcome variable separately. Statistical significance was set at p<0.05. 
  
3. Results 
 
3.1. Body weight 
Prior to surgery, body weight was 25.0±0.9 g for Npy1rrfb mice and 26.0±1.2 g for Npy1r2lox mice 
(n.s.). No significant differences between the two groups were found in body weight at the 
beginning of the experimental protocol (day 1) (Npy1rrfb: 26.3±0.3 g vs. Npy1r2lox 27.2±0.8 g).  
 
3.2. Expression of Npy1r mRNA in the hippocampus of control and conditional mutants 
In Npy1rrfb mice, Npy1r mRNA expression was significantly lower in hippocampal CA1 pyramidal 
cell layers (t=-3.1, p<0.05) and in dentate gyrus granule cell layers (t=-3.4, p<0.05) compared with 
their control littermates, whereas no difference was observed in CA3 pyramidal cell layers between 
the two groups (Fig. 2). 
 
3.3. Daily rhythms of HR, HRV, T and LOC during baseline conditions 
The daily rhythms of HR, HRV indices, T and LOC in resting conditions are depicted in Figure 3 
and summarized in Table 1. Two-way ANOVA yielded a main effect of group  for HR (F=20.1, 
p<0.01), total power (F=7.0, p<0.05), RMSSD (F=5.3, p<0.05), and HF (F=4.6, p<0.05) values. 
Follow-up analyses revealed that Npy1rrfb mice had significantly higher HR values than Npy1r2lox 
mice during both the light (t=2.9, p<0.05) and dark (t=3.9, p<0.01) phases of the daily cycle (Fig. 
3A and Table 1). Npy1rrfb mice exhibited significantly lower values of total power than Npy1r2lox 
mice during both the light (t=2.6, p<0.05) and the dark (t=3.0, p<0.01) phases of the light-dark 
cycle (Fig. 3B and Table 1). RMSSD values also resulted significantly lower in Npy1rrfb mice than 
Npy1r2lox counterparts in both phases (light: t=2.4, p<0.05; dark: t=2.5, p<0.05) (Fig. 3C and Table 
1). Also spectral power values in the HF band were lower in Npy1rrfb compared to Npy1r2lox mice 
(light: t=2.4, p<0.05; dark: t=1.9, p=0.07) (Fig. 3D and Table 1). In addition, Npy1rrfb mice had 
significantly higher T values than Npy1r2lox mice during the light phase (t=2.0, p=0.05) (Fig. 3E and 
Table 1). Lastly, no significant differences between the two groups were observed for LOC values 
(Fig. 3F and Table 1). 
 3.4. Cardiac autonomic response to the pharmacological autonomic manipulation 
Cardiac autonomic responses to vehicle or methylscopolamine injection are depicted in Figure 4. 
Before vehicle injection, HR was significantly higher in Npy1rrfb than in Npy1r2lox mice (t=2.6, 
p<0.05) (Fig. 4A). In the same period, HRV analysis revealed that Npy1rrfb mice had significantly 
lower values of RMSSD (t=2.1, p=0.05) and HF spectral power (t=2.2, p<0.05) compared to 
Npy1r2lox mice (Fig. 4C, E). The injection of vehicle provoked an increase in HR and a reduction in 
RMSSD  and HF values in both groups, with no group differences in the mean values of these 
parameters (Fig. 4A, C, E). All parameters returned to baseline values within 40 min. During the 
last 20-min recording period (min 40-60), mean HR was significantly higher in Npy1rrfb compared to 
Npy1r2lox mice (t=2.2, p<0.05) (Fig. 4A). In the same period, RMSSD and HF mean values were 
lower in Npy1rrfb than in Npy1r2lox mice (RMSSD: t=2.0, p=0.06; HF: t=2.6, p<0.05) (Fig. 4C, E). 
Before methylscopolamine injection, HR was significantly higher in Npy1rrfb compared to Npy1r2lox 
mice (t=2.3, p<0.05). Blockade of muscarinic receptors with methylscopolamine provoked a 
significant reduction of RMSSD (Npy1rrfb: t=8.5, p<0.01; Npy1r2lox: t=6.5, p<0.01) and HF (Npy1rrfb: 
t=5.4, p<0.01; Npy1r2lox: t=4.1, p<0.01) values in both groups that persisted through the 60-min 
recording period (Fig. 4D, F). There were no differences in the peak HR response to 
methylscopolamine injection between the two groups (Fig. 4B). However, contrary to what has 
been observed during vehicle (control) condition, during the last 20-min recording period (min 40-
60) mean HR was (i) similar between the two groups, and (ii) significantly higher in Npy1r2lox 
compared to the respective baseline value (t=2.2, p<0.05). 
 
3.5. HR, HRV, and LOC response to the first episode of social defeat 
Cardiac autonomic and LOC responses to the first episode of social defeat are depicted in Figure 
5. Two-way ANOVA yielded a significant effect of time for HR (F=18.9, p<0.01) and LOC (F=4.4, 
p<0.05) values. In baseline conditions, HR was significantly higher in Npy1rrfb than in Npy1r2lox 
mice (t=2.2, p<0.05) (Fig. 5A). No differences in absolute values of HR were observed between the 
two groups during the 10-min fight period and the following 60-min sensory contact phase (Fig. 
5A). However, the magnitude of the HR response during the 10-min fight period (delta values) was 
significantly smaller in Npy1rrfb than in Npy1r2lox mice (t=-4.6, p<0.01) (Fig. 5B). Consistently, in 
baseline conditions Npy1rrfb mice had significantly lower HF spectral power values compared with 
Npy1r2lox mice (t=2.5, p<0.05) (Fig. 5C). During the 10-min fight period, HF absolute values were 
similar between the two groups (Fig. 5C), with the magnitude of the stress-induced reduction in HF 
values being significantly smaller in Npy1rrfb than in Npy1r2lox mice (t=2.5, p<0.05) (Fig. 5D). No 
differences in LOC values were observed between Npy1rrfb and Npy1r
2lox mice in baseline 
conditions and in response to the social challenge (Fig. 5E, F). 
 
3.6. Daily rhythms of HR, HRV, T and LOC during chronic psychosocial stress 
HR, HRV, T and LOC values during the light and dark phases of the chronic psychosocial stress 
period are summarized in Table1. Two-way ANOVA revealed that chronic exposure to 
psychosocial stress led to (i) higher HR values (Flight=20.0, p<0.01; Fdark=19.8, p<0.01), and (ii) 
lower RMSSD (Flight=4.9, p<0.05), total power (Fdark=7.2, p<0.05) and HF (Flight=6.7, p<0.05) values 
compared to baseline conditions (Table 1). However, there were no differences between the two 
groups in HR, HRV parameters, T and LOC during both stress rhythm 1 and stress rhythm 2 
periods (Table 1).  
 
 
 
 
 
 
  
4. Discussion
This study demonstrates that reduced expression of hippocampal Y1Rs in mice is associated with 
an increase in heart rate and a decrease in vagal neural modulation at rest. 
In the present study, HRV analysis was carried out in order to characterize cardiac autonomic 
neural modulation of Npy1rrfb mice under different experimental conditions. During both the light 
and the dark phases of the daily cycle, Npy1rrfb mice exhibited a lower cardiac vagal modulation, 
as indexed by RMSSD and HF, which was likely responsible for the resting tachycardia and 
reduced overall HRV (total power) observed in these mice. Indeed, such changes could not be 
ascribed to a different level of somatomotor activity between the two groups. Rather, an important 
confirmation of the involvement of autonomic mechanisms in determining resting tachycardia in 
Npy1rrfb mice comes from the pharmacological blockade of muscarinic receptors with 
methylscopolamine. Under this condition of potent and sustained pharmacological inhibition of 
cardiac vagal modulation, and after recovery from the stress of injection (see vehicle injection 
condition for a comparison), the group difference in baseline heart rate was abolished. This was 
due to the fact that heart rate under pharmacological vagal inhibition was higher in control but not 
in Npy1rrfb mice compared to their respective baseline values. Consequently, it may be reasonable 
to hypothesize that tonic vagal influences on heart rate were reduced in Npy1rrfb mice, leading to 
resting tachycardia. Interestingly, we found that baseline body temperature values were also 
somewhat higher in Npy1rrfb mice. In rodents, brown adipose tissue (BAT) is the main site of 
nonshivering thermogenesis, and it is under tight control by the sympathetic nervous system [26]. 
Therefore, signs of hyperthermia in Npy1rrfb mice might suggest an increased sympathetic drive to 
BAT.  
In this  study, Npy1rrfb mice Y1R expression is significantly reduced in the dentate gyrus and the 
CA1 region of the hippocampus, where Y1Rs have been associated with glutamate-positive and 
NPY-positive neurons  [27]. The ventral CA1 hippocampal field is thought to be linked by 
multisynaptic connections to the sympathetic-related regions of the hypothalamus, suggesting its 
possible involvement in a higher-brain autonomic circuit [28]. In addition, the hippocampus 
connects to nucleus tractus solitarius-projecting regions of the medial prefrontal cortex (mPFC), 
such as the infralimbic cortex [29], indicating that hippocampal actions on autonomic function may 
also be routed through the mPFC. Importantly, electrical and chemical stimulation of the 
hippocampal formation in the anesthetized and the awake rat decreases heart rate, blood pressure 
and respiratory rate [30, 31]. Interestingly, pharmacological manipulation of vagal activity with 
methylatropine revealed that the cardiovascular, but not the respiratory, responses were mediated 
partially by vagal influences and partially by sympathetic influences [30]. Taken together, these 
preliminary observations indicate that hippocampal Y1Rs may participate in the control of 
autonomic outflow to peripheral tissues under baseline, undisturbed conditions. In a previous 
study,  Npy1rrfb mice have been characterized as having reduced body weight, less adipose tissue, 
and lower serum leptin levels [17]. Here, mice did not differ for body weight, either prior or after 
surgery recovery, as they were matched to avoid possible bias. Therefore, we might cautiously 
assume that body weight is not a major determinant of the autonomic phenotype described in 
Npy1rrfb mice. On the other hand, the hippocampus is an important component of the neuronal 
circuitry controlling anxiety-related behaviors and Npy1rrfb mice have been previously shown to 
display higher levels of anxiety in the elevated plus maze and open field tests [17]. These findings 
are consistent with a previous observation that overexpression of virally-transduced NPY in the 
mouse hippocampus produces anxiolytic-like effects [32]. Moreover, in humans NPY 
haploinsufficiency is correlated with trait anxiety [33]. Given that anticipation of future aversive 
events is a key aspect of anxiety disorders [34] and that anxiety is thought to be related to greater 
anticipatory reactivity in the brain [35], it is tempting to speculate that reduced vagal tone and HRV 
in Npy1rrfb mice might reflect heightened anxiety-related behavior. Following this line of reasoning, 
reduced expression of Y1Rs on neurons lying in hippocampal areas or their related circuits might 
account for the imbalance in the autonomic control of resting heart rate that characterizes high 
levels of anxiety in humans [36]  and animal models [37]. 
In this study, absolute values of HR were similar between mutant and control mice during an acute 
psychosocial challenge (social defeat). Elevated HR during social defeat was mediated by a 
decreased vagal tone compared to baseline levels in both groups. However, given that the 
concurrent stress-induced increase in HR and decrease in vagal tone were smaller in Npy1rrfb 
mice, it could be hypothesized that a failure to further decrease cardiac vagal activity contributes to 
the smaller stress-induced increase in HR in Npy1rrfb mice. Two other factors may account for the 
reduced HR response to the social challenge in these mutant mice: (i) a somewhat lower level of 
somatomotor activity, (ii) the fact that HR may have reached its physiological maximum, thus 
masking the reported differences in baseline HR. Stressful stimuli are processed in multiple limbic 
forebrain structures, including the amygdala, hippocampus and prefrontal cortex [38]. Limbic stress 
effector pathways converge on crucial subcortical relay sites, providing for downstream processing 
of limbic information. In particular, numerous studies link the hippocampus with inhibition of the 
HPA axis [38, 39]. For example, hippocampal stimulation decreases glucocorticoid secretion in rats 
and humans [40, 41], whereas hippocampal damage increases stress-induced and in some cases, 
basal glucocorticoid secretion [39]. Not surprisingly, Npy1rrfb mice show enhanced hypothalamic 
CRH immunoreactivity and higher serum corticosterone levels [17]. It has been hypothesized that 
the selective inactivation of Y1Rs in principal excitatory neurons of hippocampus might stimulate 
HPA axis via the glutamatergic output [17]. Although these limbic circuits are also thought to 
participate in autonomic integration, their precise role(s) in stress-induced responses is not yet 
defined. The results of this study provide preliminary evidence that hippocampal Y1R expression 
might also be involved in the regulation of cardiac autonomic responses to acute stress challenges. 
On the other hand, no evident differences were observed in HR and HRV parameters in response 
to the chronic psychosocial challenge employed in this study.  
In conclusion, the results of this study provide preliminary evidence that conditional reduction of 
hippocampal Y1Rs leads to signs of decreased cardiac vagal tone and HRV in mice at rest. On the 
other hand, the role of hippocampal Y1Rs in the modulation of cardiac autonomic stress response 
requires deeper investigation. We acknowledge that the robustness of these findings is certainly 
limited by several factors which need to be addressed in future experiments. For example, Y1R 
deficiency tied to certain hippocampal (e.g. glutamatergic) neurons might be useful for revealing 
the precise neurobiological pathways underlying the autonomic phenotype of Npy1rrfb mice. 
Moreover, Y1R expression should be investigated in other brain areas that may play a role in the 
cardiovascular and behavioral effects of hippocampal Y1 receptor deficiency, such as the 
infralimbic area of the mPFC. Finally, the potential contribution of other phenotypic features of 
Npy1rrfb mice (such as, reduced body weight, increased anxiety, and increased NPY and CRH 
content [17]) to the autonomic changes described in this study needs to be taken into account. 
Nevertheless, this conditional knockout mouse model might be useful for gaining a deeper 
understanding of the role of Y1Rs in emotional-processing areas of the brain for autonomic 
nervous system control. 
  
Figure captions 
Figure 1. Timeline of the experimental procedures. 
 
Figure 2. Expression of Npy1r mRNA in hippocampal CA1 and CA3 pyramidal cell layers and in 
the dentate gyrus (DG) granule cell layers in Npy1rrfb mice (n=4) and Npy1r2lox (n=4) mice. Relative 
optical densities (OD) are expressed as means ± SEM. * indicates a significant difference between 
Npy1rrfb and Npy1r2lox mice (p<0.05). 
 
Figure 3. Time course of changes in heart rate, heart rate variability parameters, body temperature 
and locomotor activity during the light (L) and the dark (D) phases of baseline daily rhythm 
recordings, in Npy1rrfb (n = 10) and Npy1r2lox (n = 8) mice. Values are reported as means ± SEM of 
data obtained by averaging multiple 2 min segments acquired every 30 min for the 12-h light and 
the 12-h dark phase of the daily cycle. RMSSD = root mean square of successive R-R interval 
differ
section.  
 
Figure 4. Time course of changes in heart rate (panels A and B), RMSSD (panels C and D) and 
high frequency (HF) power (panels E and F) in baseline conditions (bas) and following the injection 
of vehicle (left panels) or methylscopolamine (right panels) in Npy1rrfb (n = 10) and Npy1r2lox (n = 8) 
mice. Values are expressed as means ± SEM. * indicates a significant difference between Npy1rrfb
and Npy1r2lox mice (p<0.05); # indicates a significant difference vs. the respective baseline value 
(p<0.05).  
 
Figure 5. Left panels show the time course of changes in heart rate (A), high frequency (HF) power 
(C), and locomotor activity (E) values in baseline conditions (bas) and during the first episode of 
social defeat, in Npy1rrfb  (n= 10) and Npy1r2lox (n= 8) mice. Right panels show delta values of heart 
rate (B), HF power (D), and locomotor activity (F) which were calculated as the difference between 
alues are expressed as means ± 
SEM. * indicates a significant difference between Npy1rrfb and Npy1r2lox mice (p<0.05).  
  
Tables 
Table 1. Daily rhythms of HR, HRV parameters, body temperature and locomotor activity in 
baseline condition and during chronic psychosocial stress
  BASELINE RHYTHMS STRESS RHYTHMS 1 STRESS RHYTHMS 2 
  Light Dark Light Dark Light Dark 
HR  Npy1r
rfb
 504±7* 567±7* 552±14
#
 597±15 515±11 582±13 
(bpm) Npy1r
2lox
 466±12 532±5 533±14
#
 590±10
#
 497±11 571±7
#
 
TOTAL power  Npy1r
rfb
 78.7±8.3* 45.2±3.2* 39.3±6.4
# 
29.0±3.8
# 
91.9±15.8 41.4±5.6 
(ms²) Npy1r
2lox
 119.7±14.5 61.4±4.4 51.9±14.1
# 
28.7±5.6
# 
87.6±20.6 45.0±7.9 
RMSSD  Npy1r
rfb
 4.6±0.4* 3.2±0.3* 2.7±0.3
# 
2.3±0.2
# 
4.6±0.6 3.2±0.4 
(ms) Npy1r
2lox
 6.4±0.7 4.2±0.3 3.4±0.8
# 
2.8±0.4
# 
4.3±0.7
# 
3.7±0.7 
HF power  Npy1rrfb 7.4±1.4* 3.8±0.8 2.6±0.5
# 
2.1±0.4 7.1±1.7 3.6±0.9 
(ms²) Npy1r
2lox
 13.4±2.2 5.9±0.8 5.1±2.5
# 
3.2±0.9
# 
6.0±1.5
# 
5.1±1.7 
T  Npy1r
rfb
 36.2±0.2* 37.3±0.2 36.3±0.2 37.2±0.2 36.1±0.2 37.2±0.2 
(°C) Npy1r
2lox
 35.8±0.1 37.0±0.1 35.9±0.1 37.0±0.2 35.8±0.1 37.1±0.1 
LOC  Npy1r
rfb
 4.0±0.4 8.8±1.1 4.4±0.8 11.5±2.3 4.4±0.6 9.4±1.5 
(cpm) Npy1r
2lox
 4.6±0.5 11.4±1.5 5.2±0.7 12.2±1.7 4.9±0.7 12.4±1.5 
Values are reported as mean values ± SEM of data obtained by averaging multiple 2 min 
segments acquired every 30 min over a 6-day period for baseline rhythms and over a 4-day period 
for stress rhythms 1 and stress rhythms 2, in Npy1rrfb (n = 10) and Npy1r2lox (n = 8) mice. HR= heart 
rate; HRV= heart rate variability; RMSSD = root mean square of successive R-R interval 
differences; HF = high frequency; LF = low frequency; T = body temperature; LOC = locomotor 
activity. * indicates a significant difference between Npy1rrfb and Npy1r2lox mice; # indicates a 
significant difference between stress rhythm value and the respective baseline rhythm value. 
(p<0.05). 
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Abstract 
Central neuropeptide Y (NPY) signaling participates in the regulation of cardiac autonomic outflow, 
particularly via activation of NPY-Y1 receptors (Y1Rs). However, the specific brain areas and 
neural pathways involved have not been completely identified yet. Here, we evaluate the role of 
hippocampal Y1Rs in the modulation of the autonomic control of cardiac function using a 
conditional knockout mouse model. Radiotelemetric transmitters were implanted in 4-month-old 
male mice exhibiting reduced forebrain expression (rfb) of the Y1R (Npy1rrfb, n=10) and their 
corresponding controls (Npy1r2lox, n=8). ECG signals were recorded (i) during resting conditions, 
(ii) under selective pharmacological manipulation of cardiac vagal activity, and (iii) during acute and 
chronic psychosocial stress challenges, and analyzed via time- and frequency-domain analysis of 
heart rate variability. Npy1rrfb mice showed a lower Npy1r mRNA density in the dentate gyrus and 
in the CA1 region of the hippocampus. Under resting undisturbed conditions, Npy1rrfb mice 
exhibited (i) a higher heart rate, (ii) a reduced overall heart rate variability, and (iii) lower values of 
the indices of vagal modulation compared to Npy1r2lox counterparts. Following pharmacological 
vagal inhibition, heart rate was higher in control but not in Npy1rrfb mice compared to their 
respective baseline values, suggesting that tonic vagal influences on heart rate were reduced in 
Npy1rrfb mice. The magnitude of the heart rate response to an acute psychosocial stressor was 
smaller in Npy1rrfb mice compared to  Npy1r2lox counterparts (likely due to a concurrent lower vagal 
withdrawal), even though absolute heart rate values did not differ between the two groups. These 
findings suggest that reduced hippocampal Y1R expression leads to a decrease in resting vagal 
modulation and heart rate variability, which, in turn, may determine a reduced cardiac autonomic 
responsiveness to acute stress challenges. 
 
Keywords:  NPY; Stress; Heart; Autonomic; knockout; Parasympathetic.  
1. Introduction 
Neuropeptide Y (NPY) is widely distributed in the central nervous system [1], with particularly high 
concentrations in the hypothalamus [2] and limbic system [3, 4]. NPY is involved in the regulation 
of a variety of complex functions that range from food intake to emotional state [5]. These effects 
are mediated by multiple G-protein coupled receptor subtypes, which are characterized by different 
tissue localization and pharmacological properties [6-8]. In particular, accumulating evidence 
suggests that central Y1 receptors (Y1Rs) play a critical role in the inhibition of the sympathetic 
outflow to peripheral tissues. For example, it has been shown in rats that i.c.v. (lateral ventricle) 
administration of the Y1R agonist [Leu31,Pro34]NPY reduces basal noradrenaline release from the 
paraventricular nucleus of the hypothalamus (PVN) [9], the major site of autonomic regulation via 
projections to the rostral ventro-lateral medulla and the spinal cord. Moreover, NPY, acting on 
Y1Rs, decreases noradrenaline overflow from both the hypothalamus and the medulla in vitro [10]. 
A recent study has elegantly demonstrated that NPY released from the arcuate nucleus (ARC) 
suppresses tyrosine hydroxylase (TH) expression in the PVN via activation of Y1Rs [11]. This 
effect was associated with a reduction in TH expression in the locus coeruleus and other regions 
(such as the A1/C1 cell groups) in the brain stem [11], which would ultimately lead to a reduced 
sympathetic outflow to peripheral tissues [11]. Supporting this view, nanoinjection of NPY into the 
PVN decreases heart rate (HR), sympathetic nerve activity and baroreflex control of HR in 
anesthetized rats via activation of Y1Rs and Y5Rs [12]. In mice, Tovote and colleagues observed 
that bilateral i.c.v. injections of NPY dose-dependently induced bradycardia and also blunted the 
tachycardic response to a fear conditioning challenge [13], the latter via Y1R-mediated inhibition of 
stress-induced sympathetic activation [13]. Similarly, global knockout of the Y1 receptor gene in 
mice led to a larger HR activation during social defeat stress [14]. These findings support the view 
that NPY-Y1R signaling may play an important role also in constraining stress-induced sympathetic 
activation [15, 16]. While the relationship between NPY-Y1R signaling in the ARC/PVN axis and 
sympathetic nervous system has been documented, there is little known about the neural 
pathways and mechanisms that control it. Indeed, in contrast with the above reported observations 
that are suggestive of a central sympathetic inhibitory role of Y1Rs, global knockout of the NPY-
Y1R gene in mice led to resting bradycardia, which was likely due to a reduced basal sympathetic 
tone and increased parasympathetic activity [14]. This apparent contradiction might be ascribed to 
compensatory effects that are due to gene inactivation in early development and/or might underlie 
different roles played by Y1Rs at different levels in the central autonomic network.
Recently, a conditional knockout mouse model in which the inactivation of the Y1 receptor gene is 
restricted to excitatory neurons in the hippocampus, in particular when mice were reared by foster 
mothers exhibiting high levels of maternal care, has been developed [17]. Therefore, this animal 
model may be useful for understanding the contribution of hippocampal Y1Rs for central autonomic 
cardiovascular control. In order to reach this goal, autonomic modulation of cardiac function was 
assessed in the above mentioned conditional knockout mouse model during (i) baseline conditions, 
(ii) selective pharmacological autonomic manipulations, and (iii) acute and chronic psychosocial 
stress challenges, via time- and frequency-domain analysis of HR variability (HRV).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Methods 
2.1. Animals, housing conditions and ethics statements  
Experiments were performed on 4-month-old male conditional knockout mice (Npy1rrfb, n=10) and 
their control littermates (Npy1r2lox, n=8) that were matched for body weight.  Npy1rrfb and Npy1r2lox 
mice (background strain: C57BL/6J) were generated following the breeding scheme described by 
Bertocchi et al. (see [17] for details). Briefly, Npy1r2lox/Tg -tTA/LC1 mice (named herein Npy1rrfb) 
were generated using doxycycline dependent control of the Cre-LoxP system. Using this approach, 
Bertocchi et al. [17] achieved the deletion of Npy1r in the hippocampal CA1 and CA3 pyramidal 
and in the dentate gyrus granule cell layers. Since the phenotype of Npy1rrfb mutants becomes 
evident only in males reared by foster mothers showing high level of maternal cares versus 
adopted pups, immediately after birth the Npy1rrfb male mice used in our study were fostered to 
Dox-naive CD1 dams, which display high levels of maternal cares (unpublished data). Littermates 
comprising Npy1r2lox/Tg -tTA, Npy1r2lox/TgLC1, and Npy1r2lox genotypes were used as controls 
(named herein Npy1r2lox controls), as in Bertocchi et al. [17]. After weaning, mice were kept in same 
sex sibling groups in 40x20x20 cages in rooms with humidity- (50 ± 10%) and temperature- (22 ± 2 
°C) controlled conditions, with food and water available ad libitum. Experiments were performed 
during the light phase of the 12-h light/dark cycle (lights on at 7 a.m.). All experimental procedures 
and protocols were approved by the Veterinarian Animal Care and Use Committee of Parma 
University and conducted in accordance with the European Community Council Directives of 22 
September 2010 (2010/63/UE). 
 
2.2. Transmitter implantation and radiotelemetry system 
ECG (sampling frequency 2 KHz), body temperature (T, °C) and locomotor activity (LOC, counts 
per minute, cpm) signals were recorded by a radiotelemetry system. It consisted of transmitters
TA10ETA-F20, Data Sciences Int., St.Paul, MN, USA) and  platform receivers (RPC-1, Data 
Science Int., St.Paul, MN, USA), which were connected to a computer containing Art-Gold 1.10 
data acquisition system (Data Science Int., St.Paul, MN, USA). Transmitter implantation was 
performed under isoflurane anesthesia (2% in 100% oxygen), as previously described [18]. The 
intraperitoneally and two electrodes (wire loops) were fixed to the 
dorsal surface of the xyphoid process and in the anterior mediastinum close to the right atrium, 
respectively. This surgical procedure guarantees high quality ECG recordings, even during 
sustained physical activity. After surgery, mice were individually housed, injected with Gentamicin 
sulphate (Aagent, Fatro, 1ml/kg, S.C.) and allowed two weeks of recovery before the beginning of 
the experimental recordings. 
 
2.3. General experimental outline 
The timeline of the experimental protocol is depicted in Figure 1. Specific experimental procedures 
and data analysis are described in the following sections. After recovery from surgery, mice were 
weighed and left undisturbed in their home cages for 6 days (days 1-6). On days 7 and 9, they 
underwent pharmacological autonomic challenges. From day 12 to day 25, mice were housed in 
the cage of a dominant mouse in order to mimic a chronic psychosocial stress condition. At the end 
of the experimental protocol, mice were sacrificed by decapitation. Brains were rapidly removed 
and immediately frozen in liquid nitrogen, then stored at -80° C until analysis. 
 
2.4. Daily rhythms of HR, HRV, T and LOC 
ECG, T and LOC signals were sampled around-the-clock for 2 min every 30 min in baseline 
conditions (Basal Rhythms, days 1-6) and during chronic psychosocial stress (Stress Rhythms 1, 
days 16-19; Stress Rhythms 2, days 22-25) (Fig. 1). Heart rate (HR, beats per minute, bpm), HRV 
parameters (see ECG analysis section for details), T and LOC were calculated as mean values of 
the 12-h light and 12-h dark phases of the daily cycle for each recording day. Subsequently, they 
were further averaged as mean values of the light and dark phase for each recording period.  
 
2.5. Pharmacological autonomic challenge 
On day 7 and 9 (Fig. 1), mice were intraperitoneally injected with either i) vehicle (0.9% NaCl, 1 
ml/kg) or ii) methylscopolamine (muscarinic receptor antagonist, 0.1 mg/kg), with a rotational 
design. Continuous ECG recordings were performed prior to (for 30 min, baseline condition) and 
following (for 60 min) each injection, with the mice in their home cages.  
 
2.6. Chronic psychosocial stress 
In the present study we applied a modified version of the standard chronic psychosocial stress 
paradigm [18, 19], which is based on the classical resident-intruder test [20]. Six-month-old CD1 
mice were housed with a female partner for 1 week and then individually housed and trained to 
aggressively defend their territory from same sex mice intruders that were younger and lighter. 
These dominant animals served as residents. Each experimental mouse was introduced as an 
intruder in the home cage of a resident male; once there, it was attacked and subordinated by the 
resident mouse (social defeat). After 10 min, the two animals were separated by a perforated 
polystyrene-metal partition that divided the cage into two equal-area sections. Thus, the intruder 
mouse was protected from direct physical contact but it was in constant olfactory, auditory and 
visual contact with the resident (psychosocial challenge). The partition was removed five times 
during the experimental protocol (Fig. 1) at an unpredictable time between 9:00 and 13:00 h and 
repositioned after 2 min to prevent injuries. After each interaction, the experimental mice were 
closely inspected for any improper injury and were excluded from further procedures in case they 
were wounded. During the first episode of agonistic interaction, continuous ECG recordings were 
performed for 30 min in baseline conditions (with the mice in their home cage), during the 10-min 
agonistic interaction, and for 60 min after the intruders were again separated from the residents by 
the partition.  
 
2.7. Heart rate variability (HRV) analysis 
HRV analysis was carried out on ECG recordings using ChartPro 5.0 software (ADInstrument, 
Sydney, Australia), based on the recommendations for HRV analysis in mice [21].  Initially, each 
ECG recording was split in 2-min temporal segments (0-2 min; 2-4 min; etc.). Ectopic beats and 
recording artifacts were then removed following visual inspection of unprocessed ECG signals. 
Subsequently, HR and time- and frequency-domain parameters of HRV were quantified for each 2-
min time period. In the time domain, the root mean square of successive R-R interval differences 
(RMSSD, ms) was quantified; this index reflects short-term, high-frequency variations of RR 
interval, which are mainly due to cardiac parasympathetic activity [22]. In the frequency-domain, 
the power spectrum was obtained with a fast Fourier transform-
periodogram: 256 points, 50% overlap, and Hamming window). The following parameters were 
evaluated: i) the total power of the spectrum (ms2), which reflects all the cyclic components 
responsible for variability [23], and ii) the power (ms2) of the high frequency band (HF, 1.5-5.0 Hz), 
which reflects the activity of the parasympathetic nervous system and is related to respiratory sinus 
arrhythmia [24].  
 
2.8. In Situ Hybridization for Npy1r mRNA 
In situ hybridization was performed on 14- m-thick coronal brain sections, according to the 
protocol reported by Wisden and Morris [25], in Npy1rrfb (n=4) and Npy1r2lox (n=4) mice. Four 
different 40-/45-mer oligonucleotide S35-labeled probes were simultaneously used to increase the 
signal and the reaction was carried out as previously described [17]. The area of interest of clearly 
distinguishable nuclei was defined following the boundaries of the labeled regions [dentate gyrus 
granule cell layer (DG)], whereas three to four spots were used for each slice in poorly contrasted 
regions [CA1 pyramidal cell layer (CA1) and CA3 pyramidal cell layer (CA3)]. Optical densities (OD 
unit) were measured and averaged after a rodboard calibration. Background was measured by 
averaging three to five spots in the surrounding blank region of the autoradiogram, then subtracted 
from the corresponding nucleus value. 
. 
2.9. Statistical analysis 
All statistical analyses were performed using the software package SPSS (version 22). Two-way 
-subject factor (2 levels: Npy1rrfb and 
Npy1r2lox) was applied for ECG and telemetric data obtained from: i) baseline around-the-clock 
-subject factor (6 levels: day 1, 2, 3, 4, 5 and 6); ii) pharmacological 
-subject factor (4 levels: baseline; post injection 1, 2, 3); iii) first 
-subject factor (8 levels: baseline, fight, sensory 
contact 1, 2, 3, 4, 5 and 6); iv) around-the-
as within-subject factor (3 levels: baseline, stress 1 and stress 2). Follow-up analyses were 
outcome variable separately. Statistical significance was set at p<0.05. 
  
3. Results 
 
3.1. Body weight 
Prior to surgery, body weight was 25.0±0.9 g for Npy1rrfb mice and 26.0±1.2 g for Npy1r2lox mice 
(n.s.). No significant differences between the two groups were found in body weight at the 
beginning of the experimental protocol (day 1) (Npy1rrfb: 26.3±0.3 g vs. Npy1r2lox 27.2±0.8 g).  
 
3.2. Expression of Npy1r mRNA in the hippocampus of control and conditional mutants 
In Npy1rrfb mice, Npy1r mRNA expression was significantly lower in hippocampal CA1 pyramidal 
cell layers (t=-3.1, p<0.05) and in dentate gyrus granule cell layers (t=-3.4, p<0.05) compared with 
their control littermates, whereas no difference was observed in CA3 pyramidal cell layers between 
the two groups (Fig. 2). 
 
3.3. Daily rhythms of HR, HRV, T and LOC during baseline conditions 
The daily rhythms of HR, HRV indices, T and LOC in resting conditions are depicted in Figure 3 
and summarized in Table 1. Two-
p<0.01), total power (F=7.0, p<0.05), RMSSD (F=5.3, p<0.05), and HF (F=4.6, p<0.05) values. 
Follow-up analyses revealed that Npy1rrfb mice had significantly higher HR values than Npy1r2lox 
mice during both the light (t=2.9, p<0.05) and dark (t=3.9, p<0.01) phases of the daily cycle (Fig. 
3A and Table 1). Npy1rrfb mice exhibited significantly lower values of total power than Npy1r2lox 
mice during both the light (t=2.6, p<0.05) and the dark (t=3.0, p<0.01) phases of the light-dark 
cycle (Fig. 3B and Table 1). RMSSD values also resulted significantly lower in Npy1rrfb mice than 
Npy1r2lox counterparts in both phases (light: t=2.4, p<0.05; dark: t=2.5, p<0.05) (Fig. 3C and Table 
1). Also spectral power values in the HF band were lower in Npy1rrfb compared to Npy1r2lox mice 
(light: t=2.4, p<0.05; dark: t=1.9, p=0.07) (Fig. 3D and Table 1). In addition, Npy1rrfb mice had 
significantly higher T values than Npy1r2lox mice during the light phase (t=2.0, p=0.05) (Fig. 3E and 
Table 1). Lastly, no significant differences between the two groups were observed for LOC values 
(Fig. 3F and Table 1). 
 3.4. Cardiac autonomic response to the pharmacological autonomic manipulation 
Cardiac autonomic responses to vehicle or methylscopolamine injection are depicted in Figure 4. 
Before vehicle injection, HR was significantly higher in Npy1rrfb than in Npy1r2lox mice (t=2.6, 
p<0.05) (Fig. 4A). In the same period, HRV analysis revealed that Npy1rrfb mice had significantly 
lower values of RMSSD (t=2.1, p=0.05) and HF spectral power (t=2.2, p<0.05) compared to 
Npy1r2lox mice (Fig. 4C, E). The injection of vehicle provoked an increase in HR and a reduction in 
RMSSD  and HF values in both groups, with no group differences in the mean values of these 
parameters (Fig. 4A, C, E). All parameters returned to baseline values within 40 min. During the 
last 20-min recording period (min 40-60), mean HR was significantly higher in Npy1rrfb compared to 
Npy1r2lox mice (t=2.2, p<0.05) (Fig. 4A). In the same period, RMSSD and HF mean values were 
lower in Npy1rrfb than in Npy1r2lox mice (RMSSD: t=2.0, p=0.06; HF: t=2.6, p<0.05) (Fig. 4C, E). 
Before methylscopolamine injection, HR was significantly higher in Npy1rrfb compared to Npy1r2lox 
mice (t=2.3, p<0.05). Blockade of muscarinic receptors with methylscopolamine provoked a 
significant reduction of RMSSD (Npy1rrfb: t=8.5, p<0.01; Npy1r2lox: t=6.5, p<0.01) and HF (Npy1rrfb: 
t=5.4, p<0.01; Npy1r2lox: t=4.1, p<0.01) values in both groups that persisted through the 60-min 
recording period (Fig. 4D, F). There were no differences in the peak HR response to 
methylscopolamine injection between the two groups (Fig. 4B). However, contrary to what has 
been observed during vehicle (control) condition, during the last 20-min recording period (min 40-
60) mean HR was (i) similar between the two groups, and (ii) significantly higher in Npy1r2lox 
compared to the respective baseline value (t=2.2, p<0.05). 
 
3.5. HR, HRV, and LOC response to the first episode of social defeat 
Cardiac autonomic and LOC responses to the first episode of social defeat are depicted in Figure 
5. Two-way ANOVA yielded a significant effect of time for HR (F=18.9, p<0.01) and LOC (F=4.4, 
p<0.05) values. In baseline conditions, HR was significantly higher in Npy1rrfb than in Npy1r2lox 
mice (t=2.2, p<0.05) (Fig. 5A). No differences in absolute values of HR were observed between the 
two groups during the 10-min fight period and the following 60-min sensory contact phase (Fig. 
5A). However, the magnitude of the HR response during the 10-min fight period (delta values) was 
significantly smaller in Npy1rrfb than in Npy1r2lox mice (t=-4.6, p<0.01) (Fig. 5B). Consistently, in 
baseline conditions Npy1rrfb mice had significantly lower HF spectral power values compared with 
Npy1r2lox mice (t=2.5, p<0.05) (Fig. 5C). During the 10-min fight period, HF absolute values were 
similar between the two groups (Fig. 5C), with the magnitude of the stress-induced reduction in HF 
values being significantly smaller in Npy1rrfb than in Npy1r2lox mice (t=2.5, p<0.05) (Fig. 5D). No 
differences in LOC values were observed between Npy1rrfb and Npy1r
2lox mice in baseline 
conditions and in response to the social challenge (Fig. 5E, F). 
 
3.6. Daily rhythms of HR, HRV, T and LOC during chronic psychosocial stress 
HR, HRV, T and LOC values during the light and dark phases of the chronic psychosocial stress 
period are summarized in Table1. Two-way ANOVA revealed that chronic exposure to 
psychosocial stress led to (i) higher HR values (Flight=20.0, p<0.01; Fdark=19.8, p<0.01), and (ii) 
lower RMSSD (Flight=4.9, p<0.05), total power (Fdark=7.2, p<0.05) and HF (Flight=6.7, p<0.05) values 
compared to baseline conditions (Table 1). However, there were no differences between the two 
groups in HR, HRV parameters, T and LOC during both stress rhythm 1 and stress rhythm 2 
periods (Table 1).  
 
 
 
 
 
 
  
4. Discussion
This study demonstrates that reduced expression of hippocampal Y1Rs in mice is associated with 
an increase in heart rate and a decrease in vagal neural modulation at rest. 
In the present study, HRV analysis was carried out in order to characterize cardiac autonomic 
neural modulation of Npy1rrfb mice under different experimental conditions. During both the light 
and the dark phases of the daily cycle, Npy1rrfb mice exhibited a lower cardiac vagal modulation, 
as indexed by RMSSD and HF, which was likely responsible for the resting tachycardia and 
reduced overall HRV (total power) observed in these mice. Indeed, such changes could not be 
ascribed to a different level of somatomotor activity between the two groups. Rather, an important 
confirmation of the involvement of autonomic mechanisms in determining resting tachycardia in 
Npy1rrfb mice comes from the pharmacological blockade of muscarinic receptors with 
methylscopolamine. Under this condition of potent and sustained pharmacological inhibition of 
cardiac vagal modulation, and after recovery from the stress of injection (see vehicle injection 
condition for a comparison), the group difference in baseline heart rate was abolished. This was 
due to the fact that heart rate under pharmacological vagal inhibition was higher in control but not 
in Npy1rrfb mice compared to their respective baseline values. Consequently, it may be reasonable 
to hypothesize that tonic vagal influences on heart rate were reduced in Npy1rrfb mice, leading to 
resting tachycardia. Interestingly, we found that baseline body temperature values were also 
somewhat higher in Npy1rrfb mice. In rodents, brown adipose tissue (BAT) is the main site of 
nonshivering thermogenesis, and it is under tight control by the sympathetic nervous system [26]. 
Therefore, signs of hyperthermia in Npy1rrfb mice might suggest an increased sympathetic drive to 
BAT.  
In this  study, Npy1rrfb mice Y1R expression is significantly reduced in the dentate gyrus and the 
CA1 region of the hippocampus, where Y1Rs have been associated with glutamate-positive and 
NPY-positive neurons  [27]. The ventral CA1 hippocampal field is thought to be linked by 
multisynaptic connections to the sympathetic-related regions of the hypothalamus, suggesting its 
possible involvement in a higher-brain autonomic circuit [28]. In addition, the hippocampus 
connects to nucleus tractus solitarius-projecting regions of the medial prefrontal cortex (mPFC), 
such as the infralimbic cortex [29], indicating that hippocampal actions on autonomic function may 
also be routed through the mPFC. Importantly, electrical and chemical stimulation of the 
hippocampal formation in the anesthetized and the awake rat decreases heart rate, blood pressure 
and respiratory rate [30, 31]. Interestingly, pharmacological manipulation of vagal activity with 
methylatropine revealed that the cardiovascular, but not the respiratory, responses were mediated 
partially by vagal influences and partially by sympathetic influences [30]. Taken together, these 
preliminary observations indicate that hippocampal Y1Rs may participate in the control of 
autonomic outflow to peripheral tissues under baseline, undisturbed conditions. In a previous 
study,  Npy1rrfb mice have been characterized as having reduced body weight, less adipose tissue, 
and lower serum leptin levels [17]. Here, mice did not differ for body weight, either prior or after 
surgery recovery, as they were matched to avoid possible bias. Therefore, we might cautiously 
assume that body weight is not a major determinant of the autonomic phenotype described in 
Npy1rrfb mice. On the other hand, the hippocampus is an important component of the neuronal 
circuitry controlling anxiety-related behaviors and Npy1rrfb mice have been previously shown to 
display higher levels of anxiety in the elevated plus maze and open field tests [17]. These findings 
are consistent with a previous observation that overexpression of virally-transduced NPY in the 
mouse hippocampus produces anxiolytic-like effects [32]. Moreover, in humans NPY 
haploinsufficiency is correlated with trait anxiety [33]. Given that anticipation of future aversive 
events is a key aspect of anxiety disorders [34] and that anxiety is thought to be related to greater 
anticipatory reactivity in the brain [35], it is tempting to speculate that reduced vagal tone and HRV 
in Npy1rrfb mice might reflect heightened anxiety-related behavior. Following this line of reasoning, 
reduced expression of Y1Rs on neurons lying in hippocampal areas or their related circuits might 
account for the imbalance in the autonomic control of resting heart rate that characterizes high 
levels of anxiety in humans [36]  and animal models [37]. 
In this study, absolute values of HR were similar between mutant and control mice during an acute 
psychosocial challenge (social defeat). Elevated HR during social defeat was mediated by a 
decreased vagal tone compared to baseline levels in both groups. However, given that the 
concurrent stress-induced increase in HR and decrease in vagal tone were smaller in Npy1rrfb 
mice, it could be hypothesized that a failure to further decrease cardiac vagal activity contributes to 
the smaller stress-induced increase in HR in Npy1rrfb mice. Two other factors may account for the 
reduced HR response to the social challenge in these mutant mice: (i) a somewhat lower level of 
somatomotor activity, (ii) the fact that HR may have reached its physiological maximum, thus 
masking the reported differences in baseline HR. Stressful stimuli are processed in multiple limbic 
forebrain structures, including the amygdala, hippocampus and prefrontal cortex [38]. Limbic stress 
effector pathways converge on crucial subcortical relay sites, providing for downstream processing 
of limbic information. In particular, numerous studies link the hippocampus with inhibition of the 
HPA axis [38, 39]. For example, hippocampal stimulation decreases glucocorticoid secretion in rats 
and humans [40, 41], whereas hippocampal damage increases stress-induced and in some cases, 
basal glucocorticoid secretion [39]. Not surprisingly, Npy1rrfb mice show enhanced hypothalamic 
CRH immunoreactivity and higher serum corticosterone levels [17]. It has been hypothesized that 
the selective inactivation of Y1Rs in principal excitatory neurons of hippocampus might stimulate 
HPA axis via the glutamatergic output [17]. Although these limbic circuits are also thought to 
participate in autonomic integration, their precise role(s) in stress-induced responses is not yet 
defined. The results of this study provide preliminary evidence that hippocampal Y1R expression 
might also be involved in the regulation of cardiac autonomic responses to acute stress challenges. 
On the other hand, no evident differences were observed in HR and HRV parameters in response 
to the chronic psychosocial challenge employed in this study.  
In conclusion, the results of this study provide preliminary evidence that conditional reduction of 
hippocampal Y1Rs leads to signs of decreased cardiac vagal tone and HRV in mice at rest. On the 
other hand, the role of hippocampal Y1Rs in the modulation of cardiac autonomic stress response 
requires deeper investigation. We acknowledge that the robustness of these findings is certainly 
limited by several factors which need to be addressed in future experiments. For example, Y1R 
deficiency tied to certain hippocampal (e.g. glutamatergic) neurons might be useful for revealing 
the precise neurobiological pathways underlying the autonomic phenotype of Npy1rrfb mice. 
Moreover, Y1R expression should be investigated in other brain areas that may play a role in the 
cardiovascular and behavioral effects of hippocampal Y1 receptor deficiency, such as the 
infralimbic area of the mPFC. Finally, the potential contribution of other phenotypic features of 
Npy1rrfb mice (such as, reduced body weight, increased anxiety, and increased NPY and CRH 
content [17]) to the autonomic changes described in this study needs to be taken into account. 
Nevertheless, this conditional knockout mouse model might be useful for gaining a deeper 
understanding of the role of Y1Rs in emotional-processing areas of the brain for autonomic 
nervous system control. 
  
Figure captions 
Figure 1. Timeline of the experimental procedures. 
 
Figure 2. Expression of Npy1r mRNA in hippocampal CA1 and CA3 pyramidal cell layers and in 
the dentate gyrus (DG) granule cell layers in Npy1rrfb mice (n=4) and Npy1r2lox (n=4) mice. Relative 
optical densities (OD) are expressed as means ± SEM. * indicates a significant difference between 
Npy1rrfb and Npy1r2lox mice (p<0.05). 
 
Figure 3. Time course of changes in heart rate, heart rate variability parameters, body temperature 
and locomotor activity during the light (L) and the dark (D) phases of baseline daily rhythm 
recordings, in Npy1rrfb (n = 10) and Npy1r2lox (n = 8) mice. Values are reported as means ± SEM of 
data obtained by averaging multiple 2 min segments acquired every 30 min for the 12-h light and 
the 12-h dark phase of the daily cycle. RMSSD = root mean square of successive R-R interval 
section.  
 
Figure 4. Time course of changes in heart rate (panels A and B), RMSSD (panels C and D) and 
high frequency (HF) power (panels E and F) in baseline conditions (bas) and following the injection 
of vehicle (left panels) or methylscopolamine (right panels) in Npy1rrfb (n = 10) and Npy1r2lox (n = 8) 
mice. Values are expressed as means ± SEM. * indicates a significant difference between Npy1rrfb
and Npy1r2lox mice (p<0.05); # indicates a significant difference vs. the respective baseline value 
(p<0.05).  
 
Figure 5. Left panels show the time course of changes in heart rate (A), high frequency (HF) power 
(C), and locomotor activity (E) values in baseline conditions (bas) and during the first episode of 
social defeat, in Npy1rrfb  (n= 10) and Npy1r2lox (n= 8) mice. Right panels show delta values of heart 
rate (B), HF power (D), and locomotor activity (F) which were calculated as the difference between 
alues are expressed as means ± 
SEM. * indicates a significant difference between Npy1rrfb and Npy1r2lox mice (p<0.05).  
  
Tables 
Table 1. Daily rhythms of HR, HRV parameters, body temperature and locomotor activity in 
baseline condition and during chronic psychosocial stress
  BASELINE RHYTHMS STRESS RHYTHMS 1 STRESS RHYTHMS 2 
  Light Dark Light Dark Light Dark 
HR  Npy1r
rfb
 504±7* 567±7* 552±14
#
 597±15 515±11 582±13 
(bpm) Npy1r
2lox
 466±12 532±5 533±14
#
 590±10
#
 497±11 571±7
#
 
TOTAL power  Npy1r
rfb
 78.7±8.3* 45.2±3.2* 39.3±6.4
# 
29.0±3.8
# 
91.9±15.8 41.4±5.6 
(ms²) Npy1r
2lox
 119.7±14.5 61.4±4.4 51.9±14.1
# 
28.7±5.6
# 
87.6±20.6 45.0±7.9 
RMSSD  Npy1r
rfb
 4.6±0.4* 3.2±0.3* 2.7±0.3
# 
2.3±0.2
# 
4.6±0.6 3.2±0.4 
(ms) Npy1r
2lox
 6.4±0.7 4.2±0.3 3.4±0.8
# 
2.8±0.4
# 
4.3±0.7
# 
3.7±0.7 
HF power  Npy1rrfb 7.4±1.4* 3.8±0.8 2.6±0.5
# 
2.1±0.4 7.1±1.7 3.6±0.9 
(ms²) Npy1r
2lox
 13.4±2.2 5.9±0.8 5.1±2.5
# 
3.2±0.9
# 
6.0±1.5
# 
5.1±1.7 
T  Npy1r
rfb
 36.2±0.2* 37.3±0.2 36.3±0.2 37.2±0.2 36.1±0.2 37.2±0.2 
(°C) Npy1r
2lox
 35.8±0.1 37.0±0.1 35.9±0.1 37.0±0.2 35.8±0.1 37.1±0.1 
LOC  Npy1r
rfb
 4.0±0.4 8.8±1.1 4.4±0.8 11.5±2.3 4.4±0.6 9.4±1.5 
(cpm) Npy1r
2lox
 4.6±0.5 11.4±1.5 5.2±0.7 12.2±1.7 4.9±0.7 12.4±1.5 
Values are reported as mean values ± SEM of data obtained by averaging multiple 2 min 
segments acquired every 30 min over a 6-day period for baseline rhythms and over a 4-day period 
for stress rhythms 1 and stress rhythms 2, in Npy1rrfb (n = 10) and Npy1r2lox (n = 8) mice. HR= heart 
rate; HRV= heart rate variability; RMSSD = root mean square of successive R-R interval 
differences; HF = high frequency; LF = low frequency; T = body temperature; LOC = locomotor 
activity. * indicates a significant difference between Npy1rrfb and Npy1r2lox mice; # indicates a 
significant difference between stress rhythm value and the respective baseline rhythm value. 
(p<0.05). 
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